Wesfarmers shares in 2025: What to expect, growth forecasts

Retail is in for an interesting year in 2025.

| More on:
Young couple at the counter of a hardware store.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Wesfarmers Ltd (ASX: WES) shares have climbed a hefty 30% so far this year, albeit with some ups and downs along the way.

After retreating from August highs of $77.20 apiece, shares have lifted almost 9% in the past month to trade at $74.36 at the time of writing.

Looking ahead, can this retail conglomerate use its diversified portfolio to drive growth in 2025? Let's see what the experts think.

Created with Highcharts 11.4.3Wesfarmers PriceZoom1M3M6MYTD1Y5Y10YALLwww.fool.com.au

Challenges and opportunities for Wesfarmers shares

The outlook for Wesfarmers shares in 2025 will be shaped by the company's specific business lines and the economic landscape.

Analysts remain divided on the consumer discretionary stock. Goldman Sachs rates it a hold, whereas the consensus rating by brokers is a sell, according to CommSec.

Goldman's concerns are on Wesfarmers' current valuation and potentially declining margins in Kmart.

But the broker also noted the earnings power of Bunnings, along with its other growth avenues, such as healthcare and lithium.

We continue to expect Bunnings to be trading strongly and gaining share in both DIY and Trade despite a more challenging operating backdrop, and we see multiple growth options for the business as previously illustrated in our deep dive note, including Lithium and WES Health as well as Bunnings Marketplace and Retail Media.

But Wesfarmers shares are trading in line with Goldman's range of valuation estimates at a price-to-earnings (P/E) ratio of 33x, leaving the broker neutral on valuation.

It values the stock at $69.50 apiece, citing the added downside risks from lower consumer spending and a weaker retail outlook.

And Goldman may be onto something there as well.

According to the Creditor Watch 2025 Business and Economic Outlook, the retailer could "remain under some pressure" next year.

The past 12 months although prices and turnover remain much higher than before COVID. Forward orders have declined, as has profitability and business conditions.

This reflects a combination of a higher cost of living, higher interest rates and likely the pull-forward of some demand during COVID lockdowns.

Discretionary spending volumes have even declined a little, despite very strong population growth, as consumers have tightened their wallets under the aforementioned pressures.

These issues could potentially clamp discretionary spending for consumers in Australia. This could impact Wesfarmers' retail brands, including Kmart and Target, according to PAC Partners.

But at the same time, Wesfarmers is a diversified conglomerate with many lines of business.

These include non-discretionary segments, such as its healthcare portfolio and its investments in lithium.

Core business is sound

Wesfarmers shares have been pushed higher in 2024 from performance in its key brands, including Bunnings.

The home improvements warehouse continues to shine with a return on capital of 69% in FY24. Analysts expect Bunnings to remain a growth driver for the business.

Its healthcare division includes the Priceline Pharmacy and Soul Pattinson Chemist brands and isn't overly sensitive to the business cycle.

And this could be a long-term driver for the company based on broad healthcare trends.

Fidelity International says that healthcare is a "notable structural driver" due to the ageing population. It estimates that the over-65 population will double by 2050.

Meanwhile, Wesfarmers has also entered the lithium market through its stake in Covalent Lithium, which provides interesting exposure to the battery materials sector.

Wesfarmers CEO Rob Scott says the company is focused on getting its hydroxide plant up and running by mid-2025.

Wesfarmers has forecast dividends of $1.98 per share for FY25, which will grow to $2.36 by FY26 at a compound annual growth rate (CAGR) of 9.2%.

Consensus estimates also project earnings to grow at a CAGR of 9.9% over this time as well.

Foolish takeaway

Like many in the retail space, Wesfarmers shares face a challenging year ahead. High interest rates and cost-of-living pressures are weighing on consumer spending.

However, its diversified portfolio and major investments in healthcare and lithium also provide the bedrock for a running stream of earnings growth.

Even with the challenges above, consensus estimates still project the business to grow its earnings and dividends at more than 9% per year to FY26.

Wesfarmers shares have climbed 38% in the past 12 months.

Should you invest $1,000 in Arb Corporation right now?

Before you buy Arb Corporation shares, consider this:

Motley Fool investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now... and Arb Corporation wasn't one of them.

The online investing service he’s run for over a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

And right now, Scott thinks there are 5 stocks that may be better buys...

See The 5 Stocks *Returns as of 6 March 2025

Motley Fool contributor Zach Bristow has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has recommended Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Consumer Staples & Discretionary Shares

Displeased and shocked emotional young friends cooking in the kitchen.
Consumer Staples & Discretionary Shares

Breville shares fall 12% on US tariffs announcement

Breville shares are among the worst-hit ASX 200 stocks after the US announced a range of new tariffs.

Read more »

A man looking at his laptop and thinking.
Consumer Staples & Discretionary Shares

What now for Star Entertainment shares after $940M funding deal withdrawn

Negotiations between Star Entertainment and Salter Brothers Capital have ended.

Read more »

Woman checking out new laptops.
Consumer Staples & Discretionary Shares

Why are Harvey Norman shares sliding today?

What's happening with the ASX 200 furniture and electronics retailer today?

Read more »

A couple in a supermarket laugh as they discuss which fruits and vegetables to buy
Consumer Staples & Discretionary Shares

The pros and cons of buying Woolworths shares this month

Is this the right time to invest in the supermarket stock?

Read more »

A woman sprints with a trail of fire blazing from her body.
Consumer Staples & Discretionary Shares

Want to catch the boosted dividend from Harvey Norman shares? Better be quick…

The furniture and electronics retailer will pay an interim dividend of 12 cents per share on 1 May.

Read more »

Young man sitting at a table in front of a row of pokie machines staring intently at a laptop. looking at the Crown Resorts share price
Consumer Staples & Discretionary Shares

What's happening with Star Entertainment shares following casino licence decision?

Star Entertainment has updated the market on two regulatory matters and progress with its rescue plan.

Read more »

ASX 200 shares broker downgrade origami paper fortune teller with buy hold sell and dollar sign options
Consumer Staples & Discretionary Shares

Domino's shares: Buy, sell, or hold?

Should I buy Domino’s shares today or wait for a confirmed turnaround?

Read more »

a woman stands with a full grocery trolley at the top of a supermarket aisle.
Consumer Staples & Discretionary Shares

Will this secret weapon help Coles shares outperform?

This advantage could help Coles in the coming years. Here’s how.

Read more »